• 出版社/出版日：Transparency Market Research / 2022年5月
|Single User||￥764,940 (USD5,795)||▷ お問い合わせ|
|Multi User||￥1,160,940 (USD8,795)||▷ お問い合わせ|
|Corporate License||￥1,556,940 (USD11,795)||▷ お問い合わせ|
|トランスペアレンシー・マーケット・リサーチ社の本調査レポートでは、アメリカのナッツアレルギー市場市場について総合的に調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、種類別分析、治療別分析、流通チャネル別分析、競争状況などの内容をまとめております。なお、本書に掲載されている企業情報にはBayer AG、Teva Pharmaceuticals USA, Inc.、Pfizer, Inc.、Amphastar Pharmaceuticals, Inc.、Amneal Pharmaceuticals LLC.、Kaleo, Inc.などが含まれています。|
U.S. Tree Nut Allergy Market – Scope of Report
TMR’s report on the tree nut allergy market in U.S. studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the tree nut allergy market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of tree nut allergy market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the tree nut allergy market in U.S.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the tree nut allergy market in U.S.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the tree nut allergy market in U.S. These serve as valuable tools for existing market players as well as for entities interested in participating in the tree nut allergy market in U.S.
The report delves into the competitive landscape of the tree nut allergy market. Key players operating in the tree nut allergy market in U.S. have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the tree nut allergy market profiled in this report.
The research methodology is a combination of exhaustive primary and secondary research to analyze the tree nut allergy market.
Secondary research included a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we referred to include, but are not limited to:
Company websites, presentations, annual reports, white papers, technical papers, product brochures
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
Veterinary Council of U.S.
U.S.n Federation of Animal Health
Animal Welfare Board of U.S.
Mergers & Acquisitions
Thomson Mergers & Acquisitions
During the course of the research, we conducted in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents the bulk of research efforts, supplemented by extensive secondary research.
We conducted primary interviews with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who took part in the process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts
Key opinion leaders specializing in the market with respect to different industry verticals
Primary participants included, but are not limited to:
Elanco Products Company
Merck & Co., Inc.
Ceva Sante Animale
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter
Market Estimation: Market size estimations involved an in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we used modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Population, inflation rates, and others
Industry Indicators: Production data, R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived by taking into account drivers, restraints/challenges, opportunities prevailing in the market, and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise consumption data are the other pivotal factors considered to derive market forecasts.レポート目次
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: U.S. Tree Nut Allergy Market
4. Market Overview
4.1.1. Segment Definition
4.3. Market Dynamics
4.4. U.S. Tree Nut Allergy Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Overview of Tree Nut Allergy: Components, Proteins responsible for allergy
5.2. Insights on Food Allergies
5.3. Allergy Prevalence Data & Co-allergies Incidence Data in U.S
5.4. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
5.5. COVID-19 Pandemic Impact on Industry
6. U.S. Tree Nut Allergy Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Type, 2017–2031
6.4. Market Attractiveness Analysis, by Type
7. U.S. Tree Nut Allergy Market Analysis and Forecast, by Treatment
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Treatment, 2017–2031
7.4. Market Attractiveness Analysis, by Treatment
8. U.S. Tree Nut Allergy Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Distribution Channel, 2017–2031
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies
8.3.3. Online Pharmacies
8.4. Market Attractiveness Analysis, by Distribution Channel
9. Competition Landscape
9.1. Market Player – Competition Matrix (by tier and size of companies)
9.2. Company Profiles
9.2.1. Bayer AG
220.127.116.11. Company Overview (HQ, Business Segments, Employee Strength)
18.104.22.168. Product Portfolio
22.214.171.124. Financial Overview
126.96.36.199. SWOT Analysis
188.8.131.52. Strategic Overview
9.2.2. Teva Pharmaceuticals USA, Inc.
184.108.40.206. Company Overview (HQ, Business Segments, Employee Strength)
220.127.116.11. Product Portfolio
18.104.22.168. Financial Overview
22.214.171.124. SWOT Analysis
126.96.36.199. Strategic Overview
9.2.3. Pfizer, Inc.
188.8.131.52. Company Overview (HQ, Business Segments, Employee Strength)
184.108.40.206. Product Portfolio
220.127.116.11. Financial Overview
18.104.22.168. SWOT Analysis
22.214.171.124. Strategic Overview
9.2.4. Amphastar Pharmaceuticals, Inc.
126.96.36.199. Company Overview (HQ, Business Segments, Employee Strength)
188.8.131.52. Product Portfolio
184.108.40.206. Financial Overview
220.127.116.11. SWOT Analysis
18.104.22.168. Strategic Overview
9.2.5. Amneal Pharmaceuticals LLC.
22.214.171.124. Company Overview (HQ, Business Segments, Employee Strength)
126.96.36.199. Product Portfolio
188.8.131.52. Financial Overview
184.108.40.206. SWOT Analysis
220.127.116.11. Strategic Overview
9.2.6. Kaleo, Inc.
18.104.22.168. Company Overview (HQ, Business Segments, Employee Strength)
22.214.171.124. Product Portfolio
126.96.36.199. Financial Overview
188.8.131.52. SWOT Analysis
184.108.40.206. Strategic Overview
Table 01: U.S. Tree Nut Allergy Market Value (US$ Mn) Forecast, by Type, 2017‒2031
Table 02: U.S. Tree Nut Allergy Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
Table 03: U.S. Tree Nut Allergy Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031